HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of docetaxel on expression of eIF3a in human lung cancer A549 cell line.

AbstractOBJECTIVE:
To explore the dose-dependent and time-dependent effect of docetaxel on the expression of mammalian eukaryotic initiation factor 3 subunit A (eIF3a) in lung cancer cell line.
METHODS:
The human lung cancer cell line A549 was treated with gradient concentrations of docetaxel for different time. Real-time PCR and Western blot were used to detect mRNA and protein expression levels of eIF3a and alpha-tubulin, respectively.
RESULTS:
Docetaxel did not affect alpha-tubulin expression at either mRNA level or protein level. When A549 cells were treated with high concentration of docetaxel (30 μg/L), the expression level of eIF3a mRNA tended to increase in a time-dependent manner. Protein expression level of alpha-tubulin was not associated with eIF3a expression significantly in cells treated by docetaxel.
CONCLUSION:
Docetaxel could slightly increase the expression of eIF3a mRNA, and eIF3a does not regulate the expression of alpha-tubulin in A549 cells treated by docetaxel.
AuthorsZhicheng Gong, Xiaojing Xu, Ruiying Hou, Yue Guo, Feifeng Sheng, Dongsheng Ouyang, Honghao Zhou, Zhaoqian Liu
JournalZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences (Zhong Nan Da Xue Xue Bao Yi Xue Ban) Vol. 35 Issue 8 Pg. 771-6 (Aug 2010) ISSN: 1672-7347 [Print] China
PMID20818067 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • EIF3A protein, human
  • Eukaryotic Initiation Factor-3
  • RNA, Messenger
  • Taxoids
  • Tubulin
  • Docetaxel
Topics
  • Antineoplastic Agents (pharmacology)
  • Cell Line, Tumor
  • Docetaxel
  • Eukaryotic Initiation Factor-3 (genetics, metabolism)
  • Humans
  • Lung Neoplasms (pathology)
  • RNA, Messenger (genetics, metabolism)
  • Taxoids (pharmacology)
  • Tubulin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: